International Trends in Prostate-Cancer Mortality: The Decrease is Continuing and Spreading
Cancer Causes & ControlPublished 1 April 2004
Peter D. Baade, Michael Coory, Joanne F. Aitken
Citations110
SJR quartileQ2
SJR score1.18
SNIP0.91
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Significant reductions in prostate-cancer mortality were observed in United Kingdom, United States, Austria, Canada, Italy, France, Germany, Australia and Spain, and downward trends were also observable in the Netherlands, Ireland and Sweden.
Abstract
Mortality declines for prostate cancer are now evident in 12 out of the 24 developed countries considered in this analysis. Increases in PSA screening and better treatment of early-stage disease, possibly acting in combination, remain plausible hypotheses.
Keywords
Medicine
Statistics in MedicinePermutation tests for joinpoint regression with applications to cancer rates
6,069 Citations2000Hyune-Ju Kim, Michael P. Fay +2 more
A joinpoint regression model is applied to describe continuous changes in the recent trend and the grid-search method is used to fit the regression function with unknown joinpoints assuming constant variance and uncorrelated errors.
The LancetProstate cancer epidemiology
1,218 Citations2003Henrik Grönberg
Several important issues could help in understanding of this disease-the variation in incidence of prostate cancer between ethnic populations and the factors leading to familial clustering of the diseases.
Statistics in MedicineKim H‐J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. <i>Statistics in Medicine</i> 2000 <b>19</b>:335–351
890 Citations2001Hyune‐Ju Kim
The original article to which this Correction refers was published in Statistics in Medicine 2000; 19:335–351.
New England Journal of MedicineA Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
820 Citations2002Lars Holmberg, Anna Bill‐Axelson +12 more
In this randomized trial, radical prostatectomy significantly reduced disease-specific mortality, but there was no significant difference between surgery and watchful waiting in terms of overall survival.
JNCI Journal of the National Cancer InstituteCancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival Rates
659 Citations1999Benjamin F. Hankey, Eric J. Feuer +7 more
The decline in the incidence of distant stage disease holds the promise that testing for prostate-specific antigen may lead to a sustained decline in prostate cancer mortality, however, population data are complex, and it is difficult to confidently attribute relatively small changes in mortality to any one cause.
The Journal of UrologyANATOMIC RADICAL PROSTATECTOMY
562 Citations1998Patrick C. Walsh
With the reduction in morbidity, radical prostatectomy today is an ideal treatment for the cure of prostate cancer in a patient who is curable and who is going to live long enough to need to be cured.
British Journal of UrologyPatterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons
454 Citations2002M J Quinn, P. Babb
The greatest effect on the registration of new cases of prostate cancer has been the increased availability of prostate specific antigen testing during the early‐ to mid‐1990s, which is unlikely to account for much of the reduction in mortality, given the slow development of the disease from onset to death.
Annals of Internal MedicineScreening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
348 Citations2002Russell Harris, Kathleen N. Lohr
A systematic review of the evidence on screening for prostate cancer found no direct evidence connecting screening and reduced mortality, and searched for indirect evidence on the yield of screening, the efficacy and harms of various forms of treatment for early prostate cancer, and the costs and cost-effectiveness.
International Journal of CancerLarge‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial
287 Citations2001Harry J. de Koning, Anssi Auvinen +12 more
Two large‐scale randomized screening trials, the Prostate, Lung, Colorectal and Ovary (PLCO) cancer trial in the USA and the European Randomized Screening for Prostate Cancer (ERSPC) trial in Europe are currently under way, aimed at assessing whether screening reduces prostate cancer mortality.
The LancetEarly prostate cancer: clinical decision-making
219 Citations2003Ashesh B. Jani, Samuel Hellmän
The major treatment options are reviewed, their relative advantages and disadvantages are discussed, and a general approach to management of patients with early-stage prostate cancer is provided.
JNCI Journal of the National Cancer InstituteCancer Surveillance Series: Interpreting Trends in Prostate Cancer Part III: Quantifying the Link Between Population Prostate-Specific Antigen Testing and Recent Declines in Prostate Cancer Mortality
218 Citations1999Ruth Etzioni, Jack Legler +4 more
It is unlikely that the entire decline in prostate cancer mortality can be explained by PSA testing based on current beliefs concerning lead time, and only very short lead times would produce a decline in mortality of the magnitude that has been observed.
The LancetScreening for prostate cancer
217 Citations2003Stephen Frankel, George Davey Smith +2 more
Prostate cancer screening can be justified only in research programmes designed to assess its effectiveness and help identify the groups who may benefit and the balance of benefit and harm will be more favourable after risk stratification.
BMJNatural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut
217 Citations2002Grace L. Lu‐Yao, Peter C. Albertsen +4 more
More intensive screening for prostate cancer and treatment with radical prostatectomy and external beam radiotherapy among Medicare beneficiaries in the Seattle area than in the Connecticut area was not associated with lower prostate cancer specific mortality over 11 years of follow up.
CancerTrends in prostate cancer mortality among black men and white men in the United States
184 Citations2003Kenneth C. Chu, Robert E. Tarone +1 more
Investigation of possible mechanisms for the declining prostate cancer mortality rates in the United States found that the rates declined sharply after 1991 in white men and declined after 1992 in black men.
International Journal of CancerInternational trends in prostate-cancer mortality in the ?PSA era?
181 Citations2001Steven Oliver, Margaret May +1 more
New England Journal of MedicineScreening for Prostate Cancer
178 Citations2023Paul F Pinsky, Howard Parnes
The Lancet OncologySurgery, brachytherapy, and external-beam radiotherapy for early prostate cancer
135 Citations2003Richard E. Peschel, John W. Colberg
For patients with clinical stage T1c or T2 disease and a Gleason score of less than 8, 5-year biochemical disease-free survival is remarkably similar for all the above treatments, and complication rates are acceptable for all these modalities.
EpidemiologyImplications of Stage-Specific Survival Rates in Assessing Recent Declines in Prostate Cancer Mortality Rates
134 Citations2000Robert E. Tarone, Kenneth C. Chu +1 more
A decrease in U.S. prostate cancer mortality rates in white men less than 85 years of age to levels below those existing in 1986, the year use of PSA testing was approved is documented.
Urologic Clinics of North AmericaProstate cancer trends in the era of prostate-specific antigen
133 Citations2002Robert A. Stephenson
Dramatic shifts in the incidence, grade, stage, and age of men with prostate cancer have been observed with the advent of widespread PSA-based cancer detection in the United States and more biologically relevant and therapeutically amenable tumors have been identified in large numbers of patients during the PSA era.
UrologyImproved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing
95 Citations2002Edmond L. Paquette, Leon Sun +4 more
A statistically significant improved 5-year disease-specific survival and a decreased chance of dying from prostate cancer has occurred after the widespread implementation of PSA, suspecting that PSA testing has resulted in fewer patients presenting with metastatic disease and more patients presented with localized disease amenable to curative treatment.
CancerWhy is the prostate cancer death rate declining in the united states?
95 Citations1998Curtis Mettlin, Gerald P. Murphy
The National Cancer Institute recently reported data showing that the prostate cancer death rate in the United States declined between 1990 and 1995, and the overall decline was from 26.5 to 17.3 deaths per 100,000 men in the population.
Clinica Chimica ActaScreening for prostate cancer with prostate-specific antigen: beware the biases
89 Citations2002Peter S. Bunting
There is evidence to suggest that biases can have a significant impact on the utility of PSA as a screening test for PC.
PubMedTrends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.
81 Citations2003Andrew J. Coldman, Norman Phillips +1 more
No association was found between the intensity of PSA screening and subsequent decreases in prostate cancer mortality and regions with the smallest increases in incidence had the largest declines in mortality.
The Medical Journal of AustraliaProstate‐specific antigen testing in Australia and association with prostate cancer incidence in New South Wales
68 Citations1998David P. Smith, Bruce K. Armstrong
To describe patterns and trends in prostate‐specific antigen (PSA) testing in Australia and assess its role in the increasing incidence of prostate cancer, a large number of patients diagnosed with prostate cancer in Australia are receiving PSA testing.
PubMedThe European Randomized Study of Screening for Prostate Cancer: an update.
54 Citations1997B Standaert, Louis Denis
British Journal of UrologyRecent trends in the use of radical prostatectomy in England: the epidemiology of diffusion
49 Citations2003Steven Oliver, Jenny Donovan +4 more
To describe recent trends in the use of radical prostatectomy in England, there is currently no consensus on the most effective treatment for localized prostate cancer, although RP is the treatment of choice among urological surgeons for men aged < 70 years.
British Journal of CancerSurvey of the rate of PSA testing in general practice
40 Citations2001J Melia, Sue Moss
The use of prostate specific antigen (PSA) test could have a large impact on the incidence of prostate cancer in the UK and future data need to distinguish between men with and without symptoms.
CancerThe European randomized study of screening for prostate cancer
38 Citations1997B Standaert, Louis Denis
A consensus meeting on screening and global strategy for prostate carcinoma, held in Antwerp in 1994, determined the willingness among European cancer prevention centers to pursue vigorously the collaborative formation of a multinational randomized screening trial.
The Medical Journal of AustraliaSelf‐reported prevalence of pro, state‐specific antigen testing in South Australia: a community study
27 Citations1998Carole Pinnock, David Weller +1 more
To determine the prevalence and other characteristics of self‐reported blood testing (prostate‐specific antigen [PSA] for prostate cancer in the community, a large number of patients with a history of prostate cancer were surveyed.